ALNY Alnylam Pharmaceuticals Inc

USD 269.95 -3.96 ( -1.45)%
Icon

Alnylam Pharmaceuticals Inc (ALNY) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 269.95

-3.96 (-1.45)%

USD 35.33B

0.78M

USD 285.92(+5.92%)

USD 198.25 (-26.56%)

Icon

ALNY

Alnylam Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 269.95
-3.96 ( -1.45)%

Alnylam Pharmaceuticals Inc (ALNY) Stock Forecast

Show ratings and price targets of :
USD 285.92
(+5.92%)

Based on the Alnylam Pharmaceuticals Inc stock forecast from 21 analysts, the average analyst target price for Alnylam Pharmaceuticals Inc is USD 285.92 over the next 12 months. Alnylam Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Alnylam Pharmaceuticals Inc is Bullish , which is based on 8 positive signals and 3 negative signals. At the last closing, Alnylam Pharmaceuticals Inc’s stock price was USD 269.95. Alnylam Pharmaceuticals Inc’s stock price has changed by -5.91% over the past week, +0.73% over the past month and +61.31% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...